Search

Your search keyword '"Poynter J.N."' showing total 10 results
Start Over Author "Poynter J.N."
10 results on '"Poynter J.N."'

2. Ovarian cancer risk factor associations by primary anatomic site: The ovarian cancer cohort consortium.

Author

Fortner R.T., Rice M.S., Knutsen S.F., Orlich M.J., Visvanathan K., Patel A.V., Gaudet M.M., Tjonneland A., Kvaskoff M., Kaaks R., Trichopolou A., Pala V., Charlotte Onland-Moret N., Gram I.T., Amiano P., Idahl A., Allen N.E., Weiderpass E., Poynter J.N., Robien K., Giles G.G., Milne R.L., Setiawan V.W., Merritt M.A., Van Den Brandt P.A., Zeleniuch-Jacquotte A., Arslan A.A., O'Brien K.M., Sandler D.P., Wolk A., Hakansson N., Harris H.R., Trabert B., Wentzensen N., Tworoger S.S., Schouten L.J., Fortner R.T., Rice M.S., Knutsen S.F., Orlich M.J., Visvanathan K., Patel A.V., Gaudet M.M., Tjonneland A., Kvaskoff M., Kaaks R., Trichopolou A., Pala V., Charlotte Onland-Moret N., Gram I.T., Amiano P., Idahl A., Allen N.E., Weiderpass E., Poynter J.N., Robien K., Giles G.G., Milne R.L., Setiawan V.W., Merritt M.A., Van Den Brandt P.A., Zeleniuch-Jacquotte A., Arslan A.A., O'Brien K.M., Sandler D.P., Wolk A., Hakansson N., Harris H.R., Trabert B., Wentzensen N., Tworoger S.S., and Schouten L.J.

Abstract

Background: Epithelial ovarian, fallopian tube, and primary peritoneal cancers have shared developmental pathways. Few studies have prospectively examined heterogeneity in risk factor associations across these three anatomic sites. Method(s): We identified 3,738 ovarian, 337 peritoneal, and 176 fallopian tube incident cancer cases in 891,731 women from 15 prospective cohorts in the Ovarian Cancer Cohort Consortium. Associations between 18 putative risk factors and risk of ovarian, peritoneal, and fallopian tube cancer, overall and for serous and high-grade serous tumors, were evaluated using competing risks Cox proportional hazards regression. Heterogeneity was assessed by likelihood ratio tests. Result(s): Most associations did not vary by tumor site (Phet >= 0.05). Associations between first pregnancy (Phet 1/4 0.04), tubal ligation (Phet 1/4 0.01), and early-adult (age 18-21 years) body mass index (BMI; Phet 1/4 0.02) and risk differed between ovarian and peritoneal cancers. The association between early-adult BMI and risk further differed between peritoneal and fallopian tube cancer (Phet 1/4 0.03). First pregnancy and tubal ligation were inversely associated with ovarian, but not peritoneal, cancer. Higher early-adult BMI was associated with higher risk of peritoneal, but not ovarian or fallopian tube, cancer. Patterns were generally similar when restricted to serous and high-grade serous cases. Conclusion(s): Ovarian, fallopian tube, and primary peritoneal cancers appear to have both shared and distinct etiologic pathways, although most risk factors appear to have similar associations by anatomic site. Impact: Further studies on the mechanisms underlying the differences in risk profiles may provide insights regarding the developmental origins of tumors arising in the peritoneal cavity and inform prevention efforts.Copyright © 2020 American Association for Cancer Research.

Published
2021

3. Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3).

Author

Townsend M.K., Trabert B., Fortner R.T., Arslan A.A., Buring J.E., Carter B.D., Giles G.G., Irvin S.R., Jones M.E., Kaaks R., Kirsh V.A., Knutsen S.F., Koh W.-P., Lacey J.V., Langseth H., Larsson S.C., Lee I.-M., Martinez M.E., Merritt M.A., Milne R.L., O'Brien K.M., Orlich M.J., Palmer J.R., Patel A.V., Peters U., Poynter J.N., Robien K., Rohan T.E., Rosenberg L., Sandin S., Sandler D.P., Schouten L.J., Setiawan V.W., Swerdlow A.J., Ursin G., van den Brandt P.A., Visvanathan K., Weiderpass E., Wolk A., Yuan J.-M., Zeleniuch-Jacquotte A., Tworoger S.S., Wentzensen N., Townsend M.K., Trabert B., Fortner R.T., Arslan A.A., Buring J.E., Carter B.D., Giles G.G., Irvin S.R., Jones M.E., Kaaks R., Kirsh V.A., Knutsen S.F., Koh W.-P., Lacey J.V., Langseth H., Larsson S.C., Lee I.-M., Martinez M.E., Merritt M.A., Milne R.L., O'Brien K.M., Orlich M.J., Palmer J.R., Patel A.V., Peters U., Poynter J.N., Robien K., Rohan T.E., Rosenberg L., Sandin S., Sandler D.P., Schouten L.J., Setiawan V.W., Swerdlow A.J., Ursin G., van den Brandt P.A., Visvanathan K., Weiderpass E., Wolk A., Yuan J.-M., Zeleniuch-Jacquotte A., Tworoger S.S., and Wentzensen N.

Published
2021

4. The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: An analysis from the Ovarian Cancer Cohort Consortium (OC3).

Author

Rohan T.E., Sandler D.P., Schairer C., Schouten L.J., Setiawan V.W., Swerdlow A.J., Travis R.C., Trichopoulou A., Van Den Brandt P.A., Visvanathan K., Wilkens L.R., Wolk A., Zeleniuch-Jacquotte A., Wentzensen N., Trabert B., Tworoger S.S., O'Brien K.M., Townsend M.K., Fortner R.T., Iversen E.S., Hartge P., White E., Amiano P., Arslan A.A., Bernstein L., Brinton L.A., Buring J.E., Dossus L., Fraser G.E., Gaudet M.M., Giles G.G., Gram I.T., Harris H.R., Bolton J.H., Idahl A., Jones M.E., Kaaks R., Kirsh V.A., Knutsen S.F., Kvaskoff M., Lacey J.V., Lee I.-M., Milne R.L., Onland-Moret N.C., Overvad K., Patel A.V., Peters U., Poynter J.N., Riboli E., Robien K., Rohan T.E., Sandler D.P., Schairer C., Schouten L.J., Setiawan V.W., Swerdlow A.J., Travis R.C., Trichopoulou A., Van Den Brandt P.A., Visvanathan K., Wilkens L.R., Wolk A., Zeleniuch-Jacquotte A., Wentzensen N., Trabert B., Tworoger S.S., O'Brien K.M., Townsend M.K., Fortner R.T., Iversen E.S., Hartge P., White E., Amiano P., Arslan A.A., Bernstein L., Brinton L.A., Buring J.E., Dossus L., Fraser G.E., Gaudet M.M., Giles G.G., Gram I.T., Harris H.R., Bolton J.H., Idahl A., Jones M.E., Kaaks R., Kirsh V.A., Knutsen S.F., Kvaskoff M., Lacey J.V., Lee I.-M., Milne R.L., Onland-Moret N.C., Overvad K., Patel A.V., Peters U., Poynter J.N., Riboli E., and Robien K.

Abstract

Repeated exposure to the acute proinflammatory environment that follows ovulation at the ovarian surface and distal fallopian tube over a woman's reproductive years may increase ovarian cancer risk. To address this, analyses included individual-level data from 558,709 naturally menopausal women across 20 prospective cohorts, among whom 3,246 developed invasive epithelial ovarian cancer (2,045 serous, 319 endometrioid, 184 mucinous, 121 clear cell, 577 other/unknown). Cox models were used to estimate multivariable-adjusted HRs between lifetime ovulatory cycles (LOC) and its components and ovarian cancer risk overall and by histotype. Women in the 90th percentile of LOC (>514 cycles) were almost twice as likely to be diagnosed with ovarian cancer than womenin the 10th percentile (<294) [HR (95% confidence interval): 1.92 (1.60-2.30)]. Risk increased 14% per 5-year increase in LOC (60 cycles) [(1.10-1.17)]; this association remained after adjustment for LOC components: number of pregnancies and oral contraceptive use [1.08 (1.04-1.12)]. The association varied by histotype, with increased risk of serous [1.13 (1.09-1.17)], endometrioid [1.20 (1.10-1.32)], and clear cell [1.37 (1.18-1.58)], but not mucinous [0.99 (0.88-1.10), P-heterogeneity = 0.01] tumors. Heterogeneity across histotypes was reduced [P-heterogeneity = 0.15] with adjustment for LOC components [1.08 serous, 1.11 endometrioid, 1.26 clear cell, 0.94 mucinous]. Although the 10-year absolute risk of ovarian cancer is small, it roughly doubles as the number of LOC rises from approximately 300 to 500. The consistency and linearity of effects strongly support the hypothesis that each ovulation leads to small increases in the risk of most ovarian cancers, a risk that cumulates through life, suggesting this as an important area for identifying intervention strategies. Significance: Although ovarian cancer is rare, risk of most ovarian cancers doubles as the number of lifetime ovulatory cycles increases from approx

Published
2020

5. Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumours of childhood and adolescence

Author

Xu, L., primary, Pierce, J.L., additional, Sanchez, A., additional, Chen, K.S., additional, Shukla, A.A., additional, Fustino, N.J., additional, Stuart, S., additional, Bagrodia, A., additional, Krailo, M.D., additional, Shaikh, F., additional, Billmire, D., additional, Pashankar, F., additional, Bestrashniy, J., additional, Wolter Oosterhuis, J., additional, Biermann, K., additional, Gillis, A.J.M., additional, Stoop, J., additional, Xie, Y., additional, Teot, L., additional, Mora, J., additional, Poynter, J.N., additional, Rakheja, D., additional, Looijenga, L.H.J., additional, Draper, B.W., additional, Lindsay Frazier, A., additional, and Amatruda, J.F., additional

Published
2019
Full Text
View/download PDF

7. GCT-24 - Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumours of childhood and adolescence

Author

Xu, L., Pierce, J.L., Sanchez, A., Chen, K.S., Shukla, A.A., Fustino, N.J., Stuart, S., Bagrodia, A., Krailo, M.D., Shaikh, F., Billmire, D., Pashankar, F., Bestrashniy, J., Wolter Oosterhuis, J., Biermann, K., Gillis, A.J.M., Stoop, J., Xie, Y., Teot, L., Mora, J., Poynter, J.N., Rakheja, D., Looijenga, L.H.J., Draper, B.W., Lindsay Frazier, A., and Amatruda, J.F.

Published
2019
Full Text
View/download PDF

9. Risks of lynch syndrome cancers for msh6 mutation carriers

Author

Baglietto, L. (Laura), Lindor, N.M. (Noralane), Dowty, J.G. (James), White, D.M. (Darren), Wagner, A. (Anja), Gómez García, E.B. (Encarna), Vriends, A.H.J.T. (Anette), Cartwright, N.R. (Nicola), Barnetson, R.A. (Rebecca), Farrington, S.M. (Susan), Tenesa, A. (Albert), Hampel, H. (Heather), Buchanan, D. (Daniel), Arnold, S. (Sven), Young, J. (Joanne), Walsh, M.D. (Michael), Jass, J. (Jeremy), Macrae, F.A. (Finlay), Antill, Y. (Yoland), Winship, I.M. (Ingrid), Giles, G.G. (Graham), Goldblatt, J. (Jack), Parry, S. (Susan), Suthers, G. (Graeme), Leggett, B. (Barbara), Butz, M. (Malinda), Aronson, M. (Melyssa), Poynter, J.N. (Jenny), Baron, J.A. (John), Le Marchand, L. (Loic), Haile, R. (Robert), Gallinger, S. (Steve), Hopper, J.L. (John), Potter, J. (John), La Chapelle, A. (Albert) de, Vasen, H. (Hans), Dunlop, M.G. (Malcolm), Thibodeau, S.N. (Stephen), Jenkins, M.A. (Mark), Baglietto, L. (Laura), Lindor, N.M. (Noralane), Dowty, J.G. (James), White, D.M. (Darren), Wagner, A. (Anja), Gómez García, E.B. (Encarna), Vriends, A.H.J.T. (Anette), Cartwright, N.R. (Nicola), Barnetson, R.A. (Rebecca), Farrington, S.M. (Susan), Tenesa, A. (Albert), Hampel, H. (Heather), Buchanan, D. (Daniel), Arnold, S. (Sven), Young, J. (Joanne), Walsh, M.D. (Michael), Jass, J. (Jeremy), Macrae, F.A. (Finlay), Antill, Y. (Yoland), Winship, I.M. (Ingrid), Giles, G.G. (Graham), Goldblatt, J. (Jack), Parry, S. (Susan), Suthers, G. (Graeme), Leggett, B. (Barbara), Butz, M. (Malinda), Aronson, M. (Melyssa), Poynter, J.N. (Jenny), Baron, J.A. (John), Le Marchand, L. (Loic), Haile, R. (Robert), Gallinger, S. (Steve), Hopper, J.L. (John), Potter, J. (John), La Chapelle, A. (Albert) de, Vasen, H. (Hans), Dunlop, M.G. (Malcolm), Thibodeau, S.N. (Stephen), and Jenkins, M.A. (Mark)

Abstract

Background: Germline mutations in MSH6 account for 10%-20% of Lynch syndrome colorectal cancers caused by hereditary DNA mismatch repair gene

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results